Literature DB >> 29100075

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.

.   

Abstract

Sarcomas are a broad family of mesenchymal malignancies exhibiting remarkable histologic diversity. We describe the multi-platform molecular landscape of 206 adult soft tissue sarcomas representing 6 major types. Along with novel insights into the biology of individual sarcoma types, we report three overarching findings: (1) unlike most epithelial malignancies, these sarcomas (excepting synovial sarcoma) are characterized predominantly by copy-number changes, with low mutational loads and only a few genes (TP53, ATRX, RB1) highly recurrently mutated across sarcoma types; (2) within sarcoma types, genomic and regulomic diversity of driver pathways defines molecular subtypes associated with patient outcome; and (3) the immune microenvironment, inferred from DNA methylation and mRNA profiles, associates with outcome and may inform clinical trials of immune checkpoint inhibitors. Overall, this large-scale analysis reveals previously unappreciated sarcoma-type-specific changes in copy number, methylation, RNA, and protein, providing insights into refining sarcoma therapy and relationships to other cancer types.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA methylation; The Cancer Genome Atlas; dedifferentiated liposarcoma; genomics; immune infiltration; leiomyosarcoma; molecular subtype; myxofibrosarcoma; pleomorphism; undifferentiated pleomorphic sarcoma

Mesh:

Year:  2017        PMID: 29100075      PMCID: PMC5693358          DOI: 10.1016/j.cell.2017.10.014

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  82 in total

1.  Mapping short DNA sequencing reads and calling variants using mapping quality scores.

Authors:  Heng Li; Jue Ruan; Richard Durbin
Journal:  Genome Res       Date:  2008-08-19       Impact factor: 9.043

2.  The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data.

Authors:  Christopher Wilks; Melissa S Cline; Erich Weiler; Mark Diehkans; Brian Craft; Christy Martin; Daniel Murphy; Howdy Pierce; John Black; Donavan Nelson; Brian Litzinger; Thomas Hatton; Lori Maltbie; Michael Ainsworth; Patrick Allen; Linda Rosewood; Elizabeth Mitchell; Bradley Smith; Jim Warner; John Groboske; Haifang Telc; Daniel Wilson; Brian Sanford; Hannes Schmidt; David Haussler; Daniel Maltbie
Journal:  Database (Oxford)       Date:  2014-09-29       Impact factor: 3.451

3.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Authors:  Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

4.  Finding consistent patterns: a nonparametric approach for identifying differential expression in RNA-Seq data.

Authors:  Jun Li; Robert Tibshirani
Journal:  Stat Methods Med Res       Date:  2011-11-28       Impact factor: 3.021

5.  Protein-structure-guided discovery of functional mutations across 19 cancer types.

Authors:  Beifang Niu; Adam D Scott; Sohini Sengupta; Matthew H Bailey; Prag Batra; Jie Ning; Matthew A Wyczalkowski; Wen-Wei Liang; Qunyuan Zhang; Michael D McLellan; Sam Q Sun; Piyush Tripathi; Carolyn Lou; Kai Ye; R Jay Mashl; John Wallis; Michael C Wendl; Feng Chen; Li Ding
Journal:  Nat Genet       Date:  2016-06-13       Impact factor: 38.330

6.  Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

Authors:  Hussein A Tawbi; Melissa Burgess; Vanessa Bolejack; Brian A Van Tine; Scott M Schuetze; James Hu; Sandra D'Angelo; Steven Attia; Richard F Riedel; Dennis A Priebat; Sujana Movva; Lara E Davis; Scott H Okuno; Damon R Reed; John Crowley; Lisa H Butterfield; Ruth Salazar; Jaime Rodriguez-Canales; Alexander J Lazar; Ignacio I Wistuba; Laurence H Baker; Robert G Maki; Denise Reinke; Shreyaskumar Patel
Journal:  Lancet Oncol       Date:  2017-10-04       Impact factor: 41.316

7.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

8.  RADIA: RNA and DNA integrated analysis for somatic mutation detection.

Authors:  Amie J Radenbaugh; Singer Ma; Adam Ewing; Joshua M Stuart; Eric A Collisson; Jingchun Zhu; David Haussler
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

9.  Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.

Authors:  S Kasar; J Kim; R Improgo; G Tiao; P Polak; N Haradhvala; M S Lawrence; A Kiezun; S M Fernandes; S Bahl; C Sougnez; S Gabriel; E S Lander; H T Kim; G Getz; J R Brown
Journal:  Nat Commun       Date:  2015-12-07       Impact factor: 14.919

10.  A pan-cancer proteomic perspective on The Cancer Genome Atlas.

Authors:  Rehan Akbani; Patrick Kwok Shing Ng; Henrica M J Werner; Maria Shahmoradgoli; Fan Zhang; Zhenlin Ju; Wenbin Liu; Ji-Yeon Yang; Kosuke Yoshihara; Jun Li; Shiyun Ling; Elena G Seviour; Prahlad T Ram; John D Minna; Lixia Diao; Pan Tong; John V Heymach; Steven M Hill; Frank Dondelinger; Nicolas Städler; Lauren A Byers; Funda Meric-Bernstam; John N Weinstein; Bradley M Broom; Roeland G W Verhaak; Han Liang; Sach Mukherjee; Yiling Lu; Gordon B Mills
Journal:  Nat Commun       Date:  2014-05-29       Impact factor: 14.919

View more
  260 in total

1.  Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis.

Authors:  Peiwei Huangyang; Fuming Li; Pearl Lee; Itzhak Nissim; Aalim M Weljie; Anthony Mancuso; Bo Li; Brian Keith; Sam S Yoon; M Celeste Simon
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 27.287

2.  TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).

Authors:  Shuai Ye; Ying Liu; Ashley M Fuller; Rohan Katti; Gabrielle E Ciotti; Susan Chor; Md Zahidul Alam; Samir Devalaraja; Kristin Lorent; Kristy Weber; Malay Haldar; Michael A Pack; T S Karin Eisinger-Mathason
Journal:  Mol Cancer Res       Date:  2020-01-27       Impact factor: 5.852

3.  Prognostic Value of Myogenic Differentiation in Dedifferentiated Liposarcoma.

Authors:  Pawel Kurzawa; John T Mullen; Yen-Lin Chen; Sarah E Johnstone; Vikram Deshpande; Ivan Chebib; G P Nielsen
Journal:  Am J Surg Pathol       Date:  2020-06       Impact factor: 6.394

Review 4.  Challenges and Opportunities for Childhood Cancer Drug Development.

Authors:  Peter J Houghton; Raushan T Kurmasheva
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

5.  Identification of Novel Fusion Transcripts in Undifferentiated Pleomorphic Sarcomas by Transcriptome Sequencing.

Authors:  Biqiang Zheng; Shuirong Zhang; Weiluo Cai; Jian Wang; Ting Wang; Ning Tang; Yingqiang Shi; Xiaoying Luo; Wangjun Yan
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

6.  Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.

Authors:  Rebecca C Arend; Michael D Toboni; Allison M Montgomery; Robert A Burger; Alexander B Olawaiye; Bradley J Monk; Thomas J Herzog
Journal:  Oncologist       Date:  2018-08-23

Review 7.  The pathology of soft tissue sarcomas.

Authors:  Marta Sbaraglia; Angelo P Dei Tos
Journal:  Radiol Med       Date:  2018-06-12       Impact factor: 3.469

Review 8.  Dedifferentiated Liposarcoma: Systemic Therapy Options.

Authors:  Zhubin Gahvari; Amanda Parkes
Journal:  Curr Treat Options Oncol       Date:  2020-02-05

9.  Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival.

Authors:  George Z Li; Tomoyo Okada; Young-Mi Kim; Narasimhan P Agaram; Francisco Sanchez-Vega; Yawei Shen; Norifumi Tsubokawa; Jordan Rios; Axel S Martin; Mark A Dickson; Li-Xuan Qin; Nicholas D Socci; Samuel Singer
Journal:  Cancer Res       Date:  2020-03-11       Impact factor: 12.701

10.  Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.

Authors:  Naser M Ali; Stefania Niada; Anna T Brini; Mark R Morris; Sathishkumar Kurusamy; Abdullah Alholle; David Huen; Cristina R Antonescu; Franck Tirode; Vaiyapuri Sumathi; Farida Latif
Journal:  J Pathol       Date:  2018-12-27       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.